Catalyst Event

Daewoong Pharmaceutical Co Ltd (069620) · Other

From KRX Bio Technology Transfer Index (KBIOTT)

5/20/2026, 12:00:00 AM

OtherSentiment: Positive

Daewoong Pharmaceutical announced the acquisition of 'ERA' mRNA anti-aging platform assets on 2026-05-20. This strategic acquisition is estimated to cause a ≥5% price impact. scheduled

Korean Translation

2026-05-20 mRNA 기반 노화 역행 플랫폼 'ERA' 관련 자산 및 지식재산권을 인수함. 전략적 자산 확보로 5% 이상의 주가 상승이 예상됨. 예정됨

Related Recent Events

View Full Timeline